Adient (NYSE:ADNT) Stock Has Average Price Target of $24.90

Adient (NYSE:ADNT) has been assigned a consensus recommendation of “Hold” from the twelve research firms that are covering the company, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $24.90.

A number of equities research analysts have commented on the company. Barclays decreased their price target on Adient from $25.00 to $22.00 and set an “equal weight” rating on the stock in a report on Friday, October 9th. Citigroup dropped their price objective on Adient from $33.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, August 11th. UBS Group cut their target price on Adient from $29.00 to $23.00 and set a “buy” rating for the company in a research report on Wednesday, October 7th. BNP Paribas Exane raised Adient from a “neutral” rating to an “outperform” rating and set a $26.00 target price on the stock in a research note on Thursday, July 30th. Finally, Stifel Nicolaus decreased their target price on Adient from $26.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday.

Adient Stock Down 1.9%

ADNT opened at $17.60 on Tuesday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.91 and a current ratio of 1.10. Adient has a fifty-two week low of $16.51 and a fifty-two week high of $27.32. The firm’s fifty day moving average is $18.45 and its 200 day moving average is $20.05. The stock has a market cap of $1.36 billion, a price-to-earnings ratio of 29.34, a price-to-earnings-growth ratio of 0.23 and a beta of 1.60.

Adient (NYSE:ADNT) last issued its earnings results on Wednesday, August 5th. The company reported $0.48 earnings per share for the quarter, missing the consensus estimate of $0.56 by ($0.08). Adient had a return on equity of 7.32% and a net margin of 0.32%. The firm had revenue of $3.93 billion during the quarter, compared to the consensus estimate of $3.71 billion. During the same period in the prior year, the company posted $0.45 EPS. The company’s quarterly revenue was up 4.3% on a year-over-year basis. On average, sell-side analysts forecast that Adient will post 2.01 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Adient news, Director Peter Carlin sold 7,843 shares of the company’s stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $19.25, for a total value of $150,977.75. Following the completion of the transaction, the director directly owned 38,835 shares in the company, valued at $747,573.75. This represents a 16.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.94% of the stock is owned by insiders.

Institutional Investors Weigh In On Adient

Several institutional investors and hedge funds have recently modified their holdings of the stock. Parallel Advisors LLC increased its holdings in shares of Adient by 19.4% during the first quarter. Parallel Advisors LLC now owns 3,186 shares of the company’s stock valued at $64,000 after acquiring an additional 517 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Adient by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 7,538 shares of the company’s stock valued at $152,000 after purchasing an additional 705 shares during the last quarter. Corient Private Wealth LLC boosted its stake in Adient by 5.2% in the 4th quarter. Corient Private Wealth LLC now owns 18,117 shares of the company’s stock worth $347,000 after purchasing an additional 899 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in Adient by 126.4% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,838 shares of the company’s stock worth $31,000 after purchasing an additional 1,026 shares in the last quarter. Finally, Corient Private Wealth LP boosted its stake in Adient by 5.7% in the 2nd quarter. Corient Private Wealth LP now owns 19,371 shares of the company’s stock worth $356,000 after purchasing an additional 1,038 shares in the last quarter. Institutional investors own 92.44% of the company’s stock.

Adient Company Profile

Adient plc (NYSE: ADNT) is a global supplier of automotive seating systems and components. The company develops and manufactures complete vehicle seating solutions, including seats, seat structures, mechanisms, foam, trim, fabrics, and related technologies designed for passenger vehicles and commercial vehicles.

Adient serves automakers and automotive manufacturers across major vehicle-producing regions, including North America, Europe and Asia. Its products are supplied for a broad range of vehicle platforms, from traditional passenger cars and trucks to sport utility vehicles and electric vehicles.

The company was formed in 2016 through the separation of Johnson Controls’ automotive seating business and is headquartered in Dublin, Ireland, with operations and engineering capabilities located around the world.